Beta Bionics, Inc.
Company Stats
- Market Cap
- $853.9M
- as of Sep 30, 2026
- Shares Outstanding
- 45.0M
- Free Float
- 83.5%
Income Statement
- Revenue
- $100.3M
- Operating Income
- -$71.7M
- Net Income
- -$73.2M
- EBITDA
- -$70.1M
- FCF Margin, 3Y Avg
- -136.4%
- FCF Margin, Worst Year
- -273.8%
Cash Flow
- Free Cash Flow
- -$56.2M
- FCF Yield
- -6.6%
- Owner FCF Yield
- -8.5%
Balance Sheet
- Cash & Equivalents
- $31.6M
Returns & Capital
- SBC, 3Y Avg
- $9.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $100.3M | -$56.2M | -56.1% |
| FY2024 | $65.1M | -$51.7M | -79.3% |
| FY2023 | $12.0M | -$32.8M | -273.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 3, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Micro-Cap Earnings Roundup for Week of Oct. 26, 2026
Stronger demand supports expansion as pricing diverges